3M Slips After Citi Downgrade

This post was originally published on this site

Investing.com – component 3M (NYSE:) slid in midday trading Monday following a sell-side downgrade citing litigation overhang concerns over perfluoroalkyl and polyfluoroalkyl substances (PFAS).

Citi downgraded the stock to neutral from buy with a $180 price target.

Shares fell 0.5%.

“While we think MMM’s shorter-cycle end markets could be closer to a bottom and execution seems poised to improve, growing PFAS-litigation related risks could be a lingering overhang that prevents a re-rating to its former premium multiple,” Citi analyst Andrew Kaplowitz wrote.

3M (NYSE:) told Congress in September that it has not been established that PFAs cause health problems.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment